Edition:
United Kingdom

Aclaris Therapeutics Inc (ACRS.OQ)

ACRS.OQ on NASDAQ Stock Exchange Global Select Market

1.99USD
19 Jul 2019
Change (% chg)

$-0.11 (-5.24%)
Prev Close
$2.10
Open
$2.09
Day's High
$2.10
Day's Low
$1.98
Volume
88,313
Avg. Vol
191,492
52-wk High
$20.75
52-wk Low
$1.93

Get access to over 18 million research reports from over 1,700 sources.

For several years, Reuters.com has provided analyst research reports for downloading. In an effort to streamline our website, analyst research will now be available from our dedicated page for Thomson Reuters On Demand, and the Reuters service will discontinue as of September 30, 2016.

Thomson Reuters On Demand provides over 18 million research reports from 1,700 sources.

Moreover, Thomson Reuters On Demand offers fast and cost-effective solutions that would allow you to retrieve information on:

  • ownership
  • filings
  • deals
  • private equity
  • third-party document and information retrieval
  • estimates
  • fundamentals
  • economics
  • events
  • news
  • and much, much more…

Click here to request a report and the team of expert analysts will get back to you shortly, to ensure you get the report you need.

Name Age Since Current Position

Neal Walker

49 2012 President, Chief Executive Officer, Director

Frank Ruffo

52 2016 Co-Founder, Chief Financial Officer

Stuart Shanler

58 2012 Chief Scientific Officer

Kamil Ali-Jackson

60 2016 Chief Legal Officer, Chief Compliance Officer, Secretary

David Gordon

50 2018 Chief Medical Officer